![](https://investorshub.advfn.com/uicon/750370.png?cb=1607199114)
Thursday, May 04, 2023 10:57:03 AM
But anyways sure you seen this but chit I would be very happy even with 1B even.
Bucillamine Phase 3 clinical trial (NCT04504734) for #COVID-19 💊
— BITCOIN | DATA | LONG COVID (@kamtraders) May 4, 2023
By Revive Therapeutics $RVV $RVVTF
▪️DSMB meeting on May 10th, 2023 and will assess the efficacy of Bucillamine
▪️Revive expects to announce the recommendation of the DSMB meeting by May 17th, 2023.$veru $pfe pic.twitter.com/sP6M9RSec7
Ps . I know you probably.seen this possibility...
https://www.bloomberg.com/news/articles/2023-04-18/gsk-to-buy-bellus-for-2-billion-to-gain-promising-cough-drug#xj4y7vzkg
Cannabix Technologies and Omega Laboratories Inc. Provide Positive Developments on Marijuana Breathalyzer Testing • BLO • Jul 11, 2024 8:21 AM
ECGI Holdings Enhances Board with Artificial Intelligence (AI) Expert Ahead of Allon Apparel Launch • ECGI • Jul 10, 2024 8:30 AM
Avant Technologies to Meet Unmet Needs in AI Industry While Addressing Sustainability Concerns • AVAI • Jul 10, 2024 8:00 AM
Panther Minerals Inc. Launches Investor Connect AI Chatbot for Enhanced Investor Engagement and Lead Generation • PURR • Jul 9, 2024 9:00 AM
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM